Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:27 AM
Ignite Modification Date:
2025-12-25 @ 2:27 AM
NCT ID:
NCT05855434
Eligibility Criteria:
PARTICIPANTS:
Inclusion Criteria
* A patient who has been hospitalised with COVID-19 disease (with a positive Polymerase Chain Reaction (PCR) result for SARS-CoV2 infection) within NHS Grampian hospitals with subsequent subjective reporting and objective evidence of cognitive change.
* Patients aged over 18.
* Patient has completed neuropsychometric testing protocol as described above.
* Participant who is willing and able to give informed consent for participation in the study.
Exclusion Criteria
* Any patient whose physical condition will preclude them from lying still for the duration of the brain scan.
* Contraindication to magnetic resonance scanning such as an implantable cardiac device.
* Patients who required intensive care treatment for SARS-CoV2 infection.
* Patients with a pre-existing diagnosis of a Neurodegenerative disease (eg. Dementia), Intellectual Disability, previous moderate/severe brain injury or previous brain injury with noted cognitive change.
* Patients with a pre-existing neuro-inflammatory disorder (eg. Multiple Sclerosis).
* Patients under investigation for, or with a history of, cognitive change prior to hospitalisation with COVID-19 disease.
* Patients with a dependency on alcohol or recreational drugs.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
16 Years
Study:
NCT05855434
Study Brief:
Protocol Section:
NCT05855434